Azienda Ospedaliera Universitaria 'Policlinico Tor Vergata' — Roma

Public research footprint of Azienda Ospedaliera Universitaria 'Policlinico Tor Vergata', compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Crohn's Disease · Ulcerative Colitis (UC) · Relapsing Forms of Multiple Sclerosis · Immune Thrombocytopenic Purpura (ITP)

Recently updated registry entries

NCT06012240 — A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and… (Recruiting)
NCT05889182 — A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in… (Recruiting)
NCT05269004 — A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Azienda Ospedaliera Universitaria 'Policlinico Tor Vergata'?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.